ENTITY
SMARTSCORE: 3.6/5

BioStem Technologies (BSEM US)

9
Analysis
Health CareUnited States
BioStem Technologies, Inc. is a regenerative medicine company. The Company focuses on the stem cell industry for treatment in a range of rare and common degenerative diseases.
more
14 May 2025 15:00Issuer-paid

BSEM: Growth Continues to Impress

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and...

Share
13 May 2025 16:00Issuer-paid

BSEM: Growth Continues to Impress

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and...

Share
15 Apr 2025 16:00Issuer-paid

BSEM: Revenue and Earnings Blow Away Estimates

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and...

Share
24 Feb 2025 18:00Issuer-paid

BSEM: Company Receives Approval to Advance Trial

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and...

Share
18 Nov 2024 16:00Issuer-paid

BSEM: Digging Into Medicare Issue

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and...

Share
x